Rayner opens Ridley Innovation Centre

TBC Soosan Jacob
Published: Monday, April 11, 2016
Rayner has officially opened The Ridley Innovation Centre, a new £20million R&D, training and production facility in Worthing, West Sussex. The state of the art, dedicated intraocular lens (IOL) production facility has the capability of manufacturing three million intraocular lenses each year. In addition, a new Enterprise Resource Planning (ERP) quality system enables the company to trace every lens from source materials to a patient’s eye.
“The opening of The Ridley Innovation Centre marks a significant step in what we plan to be an exciting, transformative period of growth ahead of Rayner. This major investment will treble our manufacturing capacity and put us in the best position to support the company’s ambitious business expansion, ” said Tim Clover, CEO, Rayner.
The new centre has also been designed to enable training, education and research. Featuring a wet lab, library, training facilities and a museum on the history of the IOL, Rayner also plans to engage and partner surgeons and academics in new product development with a product pipeline of 11 new products in three years.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.